Direct determination of praziquantel in pharmaceutical formulations and human plasma by cathodic adsorptive stripping differential-pulse voltammetry

被引:15
作者
Ghoneim, MM [1 ]
Mabrouk, MM
Tawfik, A
机构
[1] Tanta Univ, Fac Sci, Dept Chem, Tanta 31527, Egypt
[2] Tanta Univ, Fac Pharm, Dept Analyt Chem, Tanta 31527, Egypt
关键词
praziquantel; polarography; adsorptive stripping differential-pulse voltammetry; determination in pharmaceutical forms and human plasma;
D O I
10.1016/S0731-7085(02)00457-0
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The polarographic and cyclic voltammetric behaviour of praziquantel was studied in B.R. buffers of different pH values. Contradictory to that mentioned in a previously published work, praziquantel is an electro-active compound. Its polarogram. exhibited a single 2-electron irreversible reduction wave in B.R. buffer of pH 5, the wave height decreased on the increase of pH till it disappeared in solution of pH > 7. This wave was attributed to the reduction of the C=O double bond. The quantitative trace determination of bulk praziquantel was studied at a hanging mercury drop electrode by cathodic adsorptive stripping differential-pulse voltammetry. A fully validated sensitive procedure based on controlled adsorptive accumulation of the drug onto a HMDE was developed for its direct determination without derivatization. Accumulation of praziquantel was found to be optimized in 0.1 M Na2SO4 solution as supporting electrolyte under the following conditions: accumulation potential, -1.2 V (vs. Ag/AgCl/KCls); accumulation time, 30 s; scan rate, 10 mV/s and pulse height 100 mV. The proposed procedure was applied successfully for determination of praziquantel in its pharmaceutical formulations and human plasma. The mean recoveries of the drug were 98.85-99.42% and 99.12-100.47% with RSD of 0.49-0.95% and 0.45-0.52% in pharmaceutical formulations and human plasma, respectively. Limits of detection and quantitation. of 1.14 x 10(-9) and 3.80 x 10(-9) M praziquantel, respectively, were achieved. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1311 / 1318
页数:8
相关论文
共 26 条
[1]  
*AM SOC HOSP PHARM, 1990, AHFS DRUG INF, P43
[2]   Colorimetric procedure for the microdetermination of the antibilharzial drug praziquantel and its applications to pharmaceutical formulations [J].
Amin, AS ;
Ahmed, IS .
MIKROCHIMICA ACTA, 2001, 137 (1-2) :35-40
[3]  
Britton HTS, 1952, HYDROGEN IONS
[4]   APPLICATION OF PMR SPECTROMETRY IN QUANTITATIVE-ANALYSIS OF PRAZIQUANTEL IN PHARMACEUTICAL PREPARATIONS [J].
ELKHATEEB, SZ ;
ELRAGEHY, NA ;
KHATTAB, FI ;
AHMAD, AKS .
SPECTROSCOPY LETTERS, 1990, 23 (04) :505-514
[5]   SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR PRAZIQUANTEL IN PLASMA, URINE AND LIVER HOMOGENATES [J].
GONZALEZESQUIVEL, DF ;
OKUNO, CM ;
RODRIGUEZ, MS ;
MORALES, JS ;
COOK, HJ .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 613 (01) :174-178
[6]  
GYULEMETOVA R, 1995, JPC-J PLANAR CHROMAT, V8, P241
[7]   DETERMINATION OF PRAZIQUANTEL IN MEDICATED FISH FEED AND SEDIMENT BY HPLC [J].
HORMAZABAL, V ;
YNDESTAD, M .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1995, 18 (06) :1231-1238
[8]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF PRAZIQUANTEL IN PLASMA AND TISSUES OF CULTURED FISH FOR RESIDUE AND PHARMACOKINETIC STUDIES [J].
HORMAZABAL, V ;
YNDESTAD, M .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1995, 18 (03) :589-597
[9]  
Jabor VAP, 1997, J CHROMATOGR B, V696, P307
[10]  
Jabor VAP, 2001, ELECTROPHORESIS, V22, P1399, DOI 10.1002/1522-2683(200105)22:7<1399::AID-ELPS1399>3.0.CO